Medicine & Life Sciences
Fabry Disease
100%
Enzyme Replacement Therapy
96%
agalsidase beta
66%
Diarrhea
40%
Abdominal Pain
32%
Glycosphingolipids
32%
Ranitidine
31%
atropine sulfate-diphenoxylate hydrochloride drug combination
24%
Meals
22%
Diphenoxylate
21%
Enzymes
20%
globotriaosylceramide
18%
Galactosidases
18%
Food Intolerance
17%
Sulfasalazine
16%
Inborn Errors Metabolism
15%
Vascular Endothelium
13%
Cerebrovascular Disorders
12%
Atropine
12%
Lysosomes
12%
Weight Gain
11%
Vomiting
10%
Heart Diseases
9%
Clinical Trials
8%
Quality of Life
7%
Kidney
6%
Therapeutics
6%
Chemical Compounds
Glycosphingolipid
97%
Ranitidine Hydrochloride
62%
Sulfasalazine
61%
Weight Gain
46%
Pharmacological Metabolism
28%
Error
27%
Food
26%